- This past summer Inner Mongolia Kingdomway Pharmaceutical Limited (“Kingdom”) submitted a new dietary ingredient (NDI) notification to FDA for β-Nicotinamide Mononucleotide (NMN), a compound that has been touted for its
new dietary ingredient
New Draft Guidance on FDA Enforcement Discretion for Past-Due NDI Notifications
Posted on
- The Dietary Supplement Health and Education Act of 1994 (DSHEA) requires manufacturers and distributors who wish to market a dietary supplement containing a new dietary ingredient (NDI) that has not
…
Continue Reading New Draft Guidance on FDA Enforcement Discretion for Past-Due NDI Notifications
FDA Issues Warning Letters to 11 Supplement Companies
Posted on
- On May 9, the FDA posted warning letters to 11 companies for selling adulterated dietary supplements that either contained new dietary ingredients (NDIs) for which the FDA had not received
…
Continue Reading FDA Issues Warning Letters to 11 Supplement Companies